|
1
|
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
|
Bioorg Med Chem
|
2010
|
1.40
|
|
2
|
Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.
|
PLoS One
|
2009
|
1.30
|
|
3
|
Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.
|
Annu Rev Physiol
|
2005
|
1.27
|
|
4
|
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.
|
Blood
|
2012
|
1.23
|
|
5
|
Retracted
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1.
|
Immunity
|
2003
|
1.15
|
|
6
|
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
|
Curr Drug Targets
|
2013
|
1.12
|
|
7
|
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.
|
J Biol Chem
|
2012
|
1.11
|
|
8
|
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction.
|
Antioxid Redox Signal
|
2012
|
1.04
|
|
9
|
Rejuvenating sirtuins: the rise of a new family of cancer drug targets.
|
Curr Pharm Des
|
2013
|
1.01
|
|
10
|
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts.
|
FASEB J
|
2011
|
1.01
|
|
11
|
NAD+ levels control Ca2+ store replenishment and mitogen-induced increase of cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes.
|
J Biol Chem
|
2012
|
0.96
|
|
12
|
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
|
Clin Cancer Res
|
2004
|
0.94
|
|
13
|
Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity.
|
Blood
|
2013
|
0.93
|
|
14
|
Ras-induced resistance to lapatinib is overcome by MEK inhibition.
|
Curr Cancer Drug Targets
|
2010
|
0.92
|
|
15
|
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells.
|
PLoS One
|
2011
|
0.90
|
|
16
|
Immunotherapy with dendritic cells for cancer.
|
Adv Drug Deliv Rev
|
2007
|
0.89
|
|
17
|
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
|
Leuk Res
|
2010
|
0.89
|
|
18
|
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience.
|
Semin Hematol
|
2012
|
0.88
|
|
19
|
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
|
Exp Hematol
|
2010
|
0.88
|
|
20
|
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells.
|
Autophagy
|
2013
|
0.87
|
|
21
|
Discovery of novel and selective SIRT6 inhibitors.
|
J Med Chem
|
2014
|
0.87
|
|
22
|
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
|
World J Surg Oncol
|
2013
|
0.86
|
|
23
|
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome.
|
Mediators Inflamm
|
2013
|
0.85
|
|
24
|
APO866 activity in hematologic malignancies: a preclinical in vitro study.
|
Blood
|
2009
|
0.85
|
|
25
|
The vulnerable coronary plaque: update on imaging technologies.
|
Thromb Haemost
|
2013
|
0.84
|
|
26
|
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
|
J Biol Chem
|
2013
|
0.84
|
|
27
|
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques.
|
Thromb Haemost
|
2014
|
0.84
|
|
28
|
Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders.
|
Curr Top Med Chem
|
2013
|
0.82
|
|
29
|
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.
|
Thromb Haemost
|
2013
|
0.82
|
|
30
|
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches.
|
Clin Cancer Res
|
2003
|
0.82
|
|
31
|
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
|
Clin Dev Immunol
|
2011
|
0.81
|
|
32
|
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells.
|
Eur J Immunol
|
2014
|
0.81
|
|
33
|
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
|
Leuk Lymphoma
|
2012
|
0.81
|
|
34
|
Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.
|
J Immunol
|
2003
|
0.79
|
|
35
|
Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum.
|
Mediators Inflamm
|
2013
|
0.79
|
|
36
|
New insights into biology of chronic myeloid leukemia: implications in therapy.
|
Curr Cancer Drug Targets
|
2013
|
0.78
|
|
37
|
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.
|
Curr Cancer Drug Targets
|
2013
|
0.78
|
|
38
|
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity.
|
Bioorg Med Chem Lett
|
2009
|
0.77
|
|
39
|
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes.
|
Mediators Inflamm
|
2013
|
0.77
|
|
40
|
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas.
|
Ann Hematol
|
2007
|
0.77
|
|
41
|
The role of proteasome in malignant diseases.
|
J BUON
|
2007
|
0.76
|
|
42
|
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
|
Bioorg Med Chem
|
2011
|
0.76
|
|
43
|
Selectivity hot-spots of sirtuin catalytic cores.
|
Mol Biosyst
|
2015
|
0.75
|